NCT04156490View on ClinicalTrials.gov

Osmotic Agent Use in Middle Cerebral Artery Stroke

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 10, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Ischemic StrokeMCA Infarction
Interventions
OTHER

No intervention is planned, this will be a purely retrospective trial.

Osmotic Therapy

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04156490 - Osmotic Agent Use in Middle Cerebral Artery Stroke | Biotech Hunter | Biotech Hunter